Messaging That Withstands Scrutiny

Bostonia helps healthcare AI teams de-risk how they talk about their technology—ensuring alignment with legal, ethical, and regulatory expectations from day one.

If Your Words Aren’t Clear, Your Risk Isn’t Contained

Messaging is now a legal, ethical, and strategic issue—not just a marketing one.

In healthcare, messaging is no longer cosmetic. It’s part of your product. Misleading, vague, or non-compliant language can trigger regulatory scrutiny, stall funding, or erode public trust—especially with AI involved.

Bostonia partners with legal, compliance, and product teams to proactively shape language that reflects your tech’s real capabilities, limitations, and intended impact.

What We Review

We focus on high-risk messaging across your core communications.

Patient-facing claims about AI, outcomes, and precision
Product pages, pitch decks, and investor materials
FTC, FDA, HIPAA, and WHO-aligned language reviews
Red flag phrases (“predictive,” “guaranteed,” “real-time diagnosis”)
Internal misalignment between product, legal, and comms
Explainability and informed consent narratives

Designed for High-Stakes Teams

AI-first healthcare startups
Clinical tools and diagnostic platforms
Legal and compliance leads
Scientific teams preparing for launch
VCs and accelerators reviewing portfolio risk
Public agencies and ethics councils

We support leaders building at the intersection of innovation and oversight.

Our Approach

Proactive. Collaborative. Fast.

We embed early and work across teams—before the message reaches the market.

Bostonia’s messaging audits move quickly without cutting corners. We combine our Messaging OS™ framework with legal-adjacent communication reviews to surface blind spots and help your team say what matters—clearly, accurately, and confidently.